180 related articles for article (PubMed ID: 14575152)
1. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.
Ströbel P; Helmreich M; Menioudakis G; Lewin SR; Rüdiger T; Bauer A; Hoffacker V; Gold R; Nix W; Schalke B; Elert O; Semik M; Müller-Hermelink HK; Marx A
Blood; 2002 Jul; 100(1):159-66. PubMed ID: 12070022
[TBL] [Abstract][Full Text] [Related]
3. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
4. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease.
Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072
[TBL] [Abstract][Full Text] [Related]
5. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
6. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
[TBL] [Abstract][Full Text] [Related]
7. Thymoma and paraneoplastic myasthenia gravis.
Marx A; Willcox N; Leite MI; Chuang WY; Schalke B; Nix W; Ströbel P
Autoimmunity; 2010 Aug; 43(5-6):413-27. PubMed ID: 20380583
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic autoimmunity in thymus tumors.
Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK
Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic diseases associated with thymoma.
Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
[TBL] [Abstract][Full Text] [Related]
10. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
[TBL] [Abstract][Full Text] [Related]
11. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
12. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
[TBL] [Abstract][Full Text] [Related]
13. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis.
Sempowski G; Thomasch J; Gooding M; Hale L; Edwards L; Ciafaloni E; Sanders D; Massey J; Douek D; Koup R; Haynes B
J Immunol; 2001 Feb; 166(4):2808-17. PubMed ID: 11160348
[TBL] [Abstract][Full Text] [Related]
14. Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas.
Nagane Y; Utsugisawa K; Akutsu H; Sato Y; Terayama Y
Neurology; 2005 Sep; 65(5):770-2. PubMed ID: 16157920
[TBL] [Abstract][Full Text] [Related]
15. Evidence for distinct mechanisms in the shaping of the CD4 T cell repertoire in histologically distinct myasthenia gravis-associated thymomas.
Ströbel P; Helmreich M; Kalbacher H; Müller-Hermelink HK; Marx A
Dev Immunol; 2001; 8(3-4):279-90. PubMed ID: 11785677
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
[TBL] [Abstract][Full Text] [Related]
17. CD4
Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A
Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113
[TBL] [Abstract][Full Text] [Related]
18. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
20. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
